Primer on clinical acid-base problem solving

Disease-a-Month

Volumn 50, Issue 3, 2004, Pages 122-162

  Whittier, William L ^a   Rutecki, Gregory W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANION; BICARBONATE; CARBON DIOXIDE; CHLORIDE; ELECTROLYTE; POTASSIUM ION;

ACIDEMIA; AGITATION; ANION GAP; ARTERIAL GAS; ARTERIAL PH; ARTICLE; BARTTER SYNDROME; BULIMIA; CARBON DIOXIDE TENSION; CHEMICAL ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISORDERS OF ACID BASE BALANCE; DISORIENTATION; ELECTROLYTE DISTURBANCE; ELECTROLYTE URINE LEVEL; GITELMAN SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HYPERVENTILATION; HYPOKALEMIA; HYPOVENTILATION; INFECTION; LABORATORY DIAGNOSIS; LACTIC ACIDEMIA; LACTIC ACIDOSIS; MEDICAL PRACTICE; MENTAL DISEASE; METABOLIC ALKALOSIS; PRACTICE GUIDELINE; PRIMARY HYPERALDOSTERONISM; PRIMARY MEDICAL CARE; PROBLEM SOLVING; RESPIRATORY ACIDOSIS; URINALYSIS;

ACID-BASE EQUILIBRIUM; ACID-BASE IMBALANCE; CONFUSION; EATING DISORDERS; HUMANS; HYPOKALEMIA; POTASSIUM; PSYCHOMOTOR AGITATION;

EID: 1842506630     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2004.01.002     Document Type: Article

References (48)

1. Lee C., Rutecki G.W., Clarett M., Jarjoura D., Whittier F. A comparison of interactive computerized medical education software with a more traditional teaching format. Teaching Learning Med. 9:1997;111-115.
2. Rutecki G.W., Whittier F.C. Acid-base interpretation five rules and how they help in everyday cases. Consultant. 31:1991;44-59.
3. Rutecki G.W., Whittier F.C. Acid-base interpretation five rules and how they simplify complex cases. Consultant. 31:1991;19-29.
4. Whittier F.C., Rutecki G.W. The little yellow book. Fluids and electrolytes: a guide to everyday practice. 2000;Anadem Publications.
5. Sterns RH. Fluid, electrolyte and acid-base disturbances: nephrology self-assessment program (Neph SAP). In: Glassock RJ, editor. Philadelphia (PA): Lippincott, Williams & Wilkins and American Society of Nephrology; 2003
6. Paulson W.D. How to interpret the anion gap. J Crit Illness. 12:1997;96-99.
7. Winter S.D., Pearson J.R., Gabow P.A. The fall of the serum anion gap. Arch Intern Med. 140:1990;311-313.
8. Emmet M.E., Narins R.G. Clinical use of the anion gap. Medicine. 56:1977;38-54.
9. Goldstein M.B., Bear R., Richardson K.M.A. The urine anion gap a clinically useful index of ammonium excretion. Am J Med Sci. 292:1986;198-202.
10. Giner J., Casan P., Belda J. Pain during arterial puncture. Chest. 110:1996;1443-1445.
11. Gokel Y., Paydas S., Koseoglu Z. Comparison of blood gas and acid-base measurements in arterial and venous blood samples in patients with uremic acidosis and diabetic ketoacidosis in the emergency room. Am J Nephrol. 20:2000;319-323.
12. Brandenburg M., Dire D. Comparison of arterial and venous blood gas values in the initial emergency room evaluation of patients with diabetic ketoacidosis. Ann Emerg Med. 31:1998;459-465.
13. Kelly A., McAlpin R., Kyle E. Venous pH can safely replace arterial pH in the initial evaluation. Emerg Med J. 18:2001;340-342.
14. Galla J.H. Metabolic alkalosis. J Am Soc Nephrol. 11:2000;369-375.
15. Mehler P.S. Bulimia nervosa. N Engl J Med. 349:2003;875-881.
16. Kriepe R.E., Birndorf S.A. Eating disorders in adolescents and young adults. Med Clin North Am. 84:2000;1027-1049.
17. Wolfe B.E., Metzger E.D., Levione J.M., Jimerson D.C. Laboratory screening for electrolyte abnormalities and anemia in bulimia nervosa a controlled study. Int J Eating Disord. 30:2001;288-293.
18. Greenfield D., Mickley D., Quinlan D.M., Roloff P. Hypokalemia in outpatients with eating disorders. Am J Psychiatry. 152:1995;60-63.
19. Jamison R.L., Ross J.C., Kempson R.L., Sufit C.R., Parker T.E. Surreptitious diuretic ingestion and pseudo-Bartter syndrome. Am J Med. 73:1982;142-147.
20. Wilson K.C., Reardon C., Farber H.W. Propylene glycol toxicity in a patient receiving intravenous diazepam. N Engl J Med. 343:2000;815.
21. Morgan T.J., Clark C., Calgue A. Artifactual elevation of measured plasma L-lactate concentration in the presence of glycolate. Crit Care Med. 27:1999;2177-2179.
22. Romanski SA, McMahon MM. Metabolic acidosis and thiamine deficiency 1999;74:259-63
23. Oster J.R., Singer I., Contreras G.N., Ahmad H.I., Veira C.F. Metabolic acidosis with extreme elevation of anion gap case report and literature review. Am J Med Sci. 317:1999;38-49.
24. Uribarri J., Oh M.S., Carroll H.J. D-Lactate acidosis a review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine. 77:1998;73-82.
25. Coronado B.E., Opal S.M., Yoburn D.C. Antibiotic-induces D-lactic acidosis. Ann Intern Med. 122:1995;839-842.
26. Oh M.S., Phelps K.R., Traube M., Barbosa-Saldivar J.L., Boxhill C., Carroll H.J. D-Lactic acidosis in a man with short bowel syndrome. N Engl J Med. 301:1979;73-82.
27. Graeme K.A. New drugs of abuse. Emerg Med Clin North Am. 18:2000;625-636.
28. Verebey K., Alrazi J., Jaffee J.H. The complications of "Ecstasy" (MDMA). JAMA. 259:1988;1649-1650.
29. Hyperpyrexia and rhabdomyolysis after MDMA ("Ecstasy") abuse. Lancet. 339:1992;677-678.
30. Fahal I.H., Sallomi D.F., Yaqoob M., Bell G.M. Acute renal failure after Ecstasy. BMJ. 305:1992;29.
31. Epstein S.K., Singh N. Respiratory acidosis. Respir Care. 46:2001;366-383.
32. Foter G.T., Varizi N.D., Sassoon C.S. Respiratory alkalosis. Respir Care. 46:2001;384-391.
33. Saxena R., Rutecki G.W., Whitter F.C. Enterovesical fistula presenting as life-threatening normal anion gap metabolic acidemia. Am J Kidney Dis. 30:1997;131-133.
34. Bartholow C., Whittier F.C., Rutecki G.W. Hypokalemia and metabolic alkalosis algorithms for combined clinical problem solving. Comp Ther. 26:2000;114-120.
35. Guay-Woodford L.M. Bartter syndrome unraveling the pathophysiologic enigma. Am J Med. 105:1998;151-161.
36. Simon D.B., Nelson-Williams C., Johnson Bia M. Gitelman variant of Barrter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Gen. 12:1996;24-28.
37. Schwartz G.L., Chapman A.B., Boerwinkle E., Kisabeth R.M., Turner S.T. Screening for primary aldosteronism implications of an increased plasma aldosterone/renin ratio. Clin Chem. 48:2002;1919-1923.
38. Ganguly A. Primary aldosteronism. N Engl J Med. 339:1998;1828-1834.
39. Bakris GL. Hypertension: nephrology self assessment program 2003;2:199-233
40. Biglieri E.G., Irony I., Kater C.E. Identification and implications of new types of mineralocorticoid hypertension. J Steroid Biochem. 32:1989;199-204.
41. Scheinman S.J., Guay-Woodford L.M., Thakker R.V., Warnock D.G. Genetic disorders of renal electrolyte transport. N Engl J Med. 340:1999;1177-1187.
42. Messiaen T, Deret S, Mougenot B, Bridoux F, Dequiedt P, Dion J, et al. Adult Fanconi Syndrome secondary to light chain gammopathy: clinicopathologic heterogeneity and unusual features in 11 patients. Medicine 2000;79:135-54
43. Haga H.J., Berg K.J., Aasarod K., Hammerstrom J., Jorstad S. Renal involvement in primary Sjogren syndrome. Q J Med. 93:2000;297-304.
44. Rose BD, Post TW. Clinical physiology of acid-base and electrolyte disorders. 5th edition. New York, NY: McGraw-Hill Co, Inc; 1994: p 551-77, 844-54
45. John M., Malla S. Hyperlactanemia syndromes in people with HIV infection. Curr Opin Infect Dis. 15:2002;23-29.
46. Shaer A.J., Rastegar A. Lactic acidosis in the setting of antiretroviral therapy for the acquired immunodeficiency syndrome. Am J Nephrol. 20:2000;332-338.
47. Cote H.C., Brumme Z.L., Craib K.J. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med. 346:2002;811-820.
48. Fouty B., Frerman F., Reves R. Riboflavin to treat nucleoside analogue-induced lactic acidosis. Lancet. 352:1998;291.